ABSTRACT: Coordinated serotonin (5-HT) synthesis and reuptake depends on coexpression of Tph2, Aadc (Ddc) and Sert (Slc6a4) in brain 5-HT neurons. However, other gene products play critical roles in brain 5-HT synthesis and transport. For example, 5-HT synthesis depends on coexpression of genes encoding the enzymatic machinery necessary for the production and regeneration of tetrahydrobiopterin (BH4).
3 Keywords: Serotonin, tetrahydrobiopterin, Organic cation transporter 3, Pet-1, GTP cyclohydrolase I, GTP cyclohydrolase I feedback regulator, Quinoid dihydropteridine reductase. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 4 INTRODUCTION: Coexpression of unique gene combinations encoding numerous kinds of neuron-type and pan neuronal characteristics establishes the identity of different neurons (1) . However, the gene regulatory mechanisms controlling the acquisition of neuron-type identities are poorly understood. One key and obvious identity feature that distinguishes different neuron types is transmitter identity.
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Transmitter identity is commonly defined by the presence of a particular transmitter together with the coexpression of genes required for its synthesis, reuptake, and vesicular transport in specific neuron-types (2) . A serotonergic gene regulatory network, comprising multiple interacting transcription factors, has been identified that coordinates expression of Tph2, Aadc, Sert, Vmat2, 5-HT1a, and 5-HT1b in brain 5-HT neurons (3) . Transcription factors Ascl1, Nkx2.2, and Foxa2 are required for specification of serotonergic progenitors in the ventral hindbrain. These factors subsequently activate a downstream transcription factor network comprising, Gata-2, Insm1, Gata3, Lmx1b, Engrailed1/2, and Pet-1, which acts in postmitotic serotonergic precursors to initiate 5-HT neuron-type differentiation (4) (5) (6) (7) (8) (9) .
Germ line targeting of each of these factors results in aborted differentiation to varying extents depending on which factor is missing (3) . For example, the Pet-1 ETS factor is required for coordinate expression of Tph2, Ddc, Slc6a4, Slc18a2, Htr1a, and Htr1b in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 postmitotic serotonergic precursors as expression of each of these 5-HT identity genes is severely reduced in Pet-1 -/-5-HT neurons (7, 10, 11) . In vivo chromatin immunoprecipitation and in vitro DNA binding assays have demonstrated that Pet-1 coordinates expression of these serotonergic genes through direct binding to a common conserved ETS DNA binding site in their promoter regions (11, 12) . Although Pet-1 is expressed in what appears to be all brain 5-HT neurons, Tph2 continues to be expressed, albeit at reduced levels, in a subset of Pet-1 -/-5-HT neurons suggesting the presence of a Pet-1 resistant subpopulation of 5-HT neurons (7, 10, 13) .
In addition to the genes described above, other gene products play critical roles in 5-HT synthesis and transport and therefore are necessary for 5-HT to function as a transmitter. For example, in addition to Tph2 and Aadc, 5-HT synthesis depends on coordinate expression of the enzymatic machinery catalyzing the production and regeneration of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4), an obligatory cofactor for Tph2 enzymatic activity as well as the enzymatic activity of other monoaminergic monooxygenases, nitric oxide synthases, and alkylglycerol monooxygenase (14) (15) (16) (17) . BH4
is synthesized de novo from the precursor guanosine triphosphate (GTP) in four or five enzymatic steps ( Figure 1 ) catalyzed by GTP cyclohydrolase I (Gtpch, gene symbol Figure 1 ) (14) . Although, it is commonly accepted that Tph2 is a rate-limiting step for the production of 5-HT, Gtpch (18, 19) . The allosteric binding of BH4 to
Gtpch stimulates the formation of a multimeric Gfrp:Gtpch complex in which Gtpch activity is inhibited (19, 20) . In contrast, L-phenylalanine can stimulate BH4 biosynthesis in a Gfrp-dependent manner (21) . After its enzymatic conversion to 4α-hydroxytetrahydrobiopterin in a monooxygenase or synthase reaction, BH4 can be regenerated in a two-step pathway catalyzed by pterin-4α-carbinolamine dehydratase (PCD, gene symbol Pcbd1 and Pcbd2) and dihydropteridine reductase (Dhpr, gene symbol Qdpr, quinoid dihydropteridine reductase) (15) . A large number of rare mutations, causing BH4
and monoamine deficiency, have been identified in human GCH1, PTS, SPR, PCBD1, and QDPR genes and are responsible for several neurological motor control disorders such as dopa-responsive dystonia or Segawa disease (22) . The 5-HT transporter, Sert (gene symbol Slc6a4), is responsible for high affinity reuptake of 5-HT (23, 24) . However, other transporters are now recognized as playing important roles in clearing 5-HT from the synaptic cleft and extrasynaptic sites (25) . For example, Oct3 (gene symbol Slc22a3)
has been shown to function as a low affinity, high capacity 5-HT transporter (26) . Oct3 expression is abundant in brain 5-HT neurons and importantly it is a critical determinant of SSRI efficacy (27) . However, the regulatory mechanisms that control expression of BH4 and Slc22a3 genes in 5-HT neurons have not been investigated.
A possibility is that a regulatory network distinct from that controlling Tph2, Ddc, Slc6a4, Slc18a2, Htr1a, and Htr1b, controls these additional key serotonergic genes. This possibility seems plausible as BH4 enzymatic pathways are expressed in numerous neural and non-neural cell types of the brain and periphery and are required for other cellular functions in addition to 5-HT synthesis (14, 15) . Similarly, Oct3 is widely expressed in many different neuron-types and glia of the adult rodent brain unlike Tph2, Sert, and Vmat2 (28, 29) . Alternatively, as for other neural expressed genes (30, 31) the complex expression patterns of Oct3 and BH4 genes might be generated through separate cis regulatory control modules one of which positively responds to the same transcription factors that control other serotonergic genes such as Tph2.
To begin to understand the regulatory mechanisms that control Oct3 expression and BH4 production in mouse 5-HT neurons, we investigated whether their serotonergic expression is controlled by Pet-1. We previously reported a microarray method for transcriptome studies of flow sorted yellow fluorescent protein (YFP) -expressing fetal 5-HT neurons obtained from the ePet-EYFP transgenic mouse line (32, 33) . Here, we present a protocol for flow sorting of ePet-EYFP-marked Pet-1 -/-5-HT neurons from the fetal rostral hindbrain. We used this new protocol for comparative microarray analyses of Slc22a3 and BH4 gene expression in wild type and Pet-1 -/-5-HT neurons. In addition,
we investigated the relative Pet-1 dependency of serotonergic genes in the adult dorsal raphe. 
Results and Discussion
In previous histochemical studies, we found comparable numbers of Pet-1 -/-5-HT neuron cells bodies and wild type 5-HT neuron cell bodies in the midbrain dorsal raphe (34) . domains were dissected, dissociated and purified by flow cytometry as previously described (33) . Because Pet-1 may regulate the rostral and caudal 5-HT system differently, we only used tissue form the rostral 5-HT system which gives rise to the dorsal and median raphe and B9 nuclei.
Both +/+ and Pet-1 -/-5-HT neurons were readily sorted ( Figure 2C -F) and comparable numbers were obtained ( Figure 2G ). RT-qPCR revealed, as expected, a complete lack of Pet-1 expression in YFP + RNA isolated from Pet-1 -/-rostral hindbrain ( Figure 2H ). Moreover, Tph2 and Slc6a4 RNA levels were also dramatically reduced in
Pet-1 -/-embryos compared to control levels as expected (7) . Importantly, the expression of Lmx1b a serotonergic transcription factor whose expression is independent of Pet-1 at fetal stages was unchanged (5) . Thus, flow sorted Pet-1 -/-YFP + 5-HT neurons can be Figure 3A ) to extents that correlate well with previous histochemical studies of these genes in Pet-1 -/-mice. We also note that expression of Lmx1b, a gene not regulated by Pet-1 in fetal 5-HT neurons (5, 11) , was not altered in the present microarray analysis of its expression in mutant 5-HT neurons. Our array findings indicated very low expression of Hrt1a and Hrtr1b, which is consistent with our earlier findings that expression of these two autoreceptor genes is not strongly induced until after E14 (11) . Thus, the very low, near background levels, of these genes at E12. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Importantly, our array findings for Tph2, Ddc, Slc6a4, Slc18a2, Htr1a, and Lmx1b were perfectly consistent with our previously published studies of their Pet-1 dependency (35) .
Having demonstrated the validity of our array approach for reproducible and accurate detection of gene expression changes in response to loss of Pet-1 we analyzed our datasets for expression of Slc22a3 and BH4 genes ( Figure 3B ).
Examination of the +/+ arrays revealed that in comparison to Pet-1 and other 5-HT genes, Slc22a3, Gchfr, Qdpr, and Pcbd1 are robustly expressed at E12.5. Gchfr was the most abundantly expressed BH4 gene in our dataset, which is consistent with previous studies showing strong expression of this feedback regulator gene in adult rat (21) and as shown here it is expressed strongly in a serotonergic pattern in the adult mouse dorsal raphe ( Figure 3C ). In contrast, its expression is undetectable in other brain monoaminergic neuron types. This suggests that BH4 production in 5-HT neurons is especially sensitive to Gfrp-dependent BH4 negative feedback and Gfrpdependent L-Phe stimulation of BH4 biosynthesis (21) . One possibility is that this provides for rapid and precise adjustments in 5-HT synthetic rates in response to changing behavioral and metabolic states. The Pcbd1 paralog, Pcbd2, has a relatively low expression level (Pcbd1 average probe intensity: 1897±239, Pcbd2: 384±13)
5-HT neurons
suggesting Pcbd1 plays the major role in BH4 regeneration in 5-HT neurons. Although, Gchfr, Qdpr, and Pcbd1 were robustly expressed at E12.5, Gch1, Pts and Spr expression was relatively low ( Figure 3B) . Yet, the level of Gch1, Pts, and Spr expression must be adequate to support evident abundant synthesis of 5-HT at this fetal stage. ISH confirmed that by adulthood, Gch1 is indeed strongly expressed in the mouse dorsal raphe ( Figure 3D ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Besides SR, several other enzymes can catalyze the last three steps of the de novo BH4 synthesis pathway. Of these, enzymes encoded by Akr1b3, and Cbr1 but not Akr1c18 are robustly expressed at E12.5 suggesting multiple BH4 synthesis pathways may be involved in 5-HT synthesis in immature 5-HT neurons ( Figure 3B, Figure 1) ).
Finally, the regeneration/salvage gene, DHFR, is weakly expressed in immature 5-HT neurons ( Figure 3B ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 their expression at least at E12.5. One possibility is that Lmx1b or Gata-3 is required for expression of these other BH4 synthesis, regeneration, and salvage pathway genes.
Alternatively, all three transcription factors may play compensatory roles in the expression of these genes so that removal of a single regulatory partner has little or no effect on expression of these genes. A final possibility is that the more broadly expressed broadly functional BH4 genes such as Akr1b3 are controlled by another gene regulatory network. Although we obtained highly concordant array results among our biological replicates for Slc22a3, Gch1, Gchfr and Qdpr dependence on Pet-1, we selected Slc22a3 for RT-qPCR verification using dissected E12.5 neural tubes ( Figure 4A ).
Consistent with the array results, we detected significantly reduced expression of Tph2, Slc6a4, and Slc22a3 but not Lmx1b in Pet-1 -/-neural tubes ( Figure 4A ).
We next investigated adult Slc22a3 expression with in situ hybridization (ISH).
Consistent with the Allen Brain Atlas ISH analysis of Slc22a3, we found a highly restricted serotonergic raphe pattern of expression for this gene in the midbrain and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 pons ( Figure 4B , left panel and data not shown) suggesting a highly selective serotonergic role for this gene in these brain regions. (7, 13) , which is shown here in Figure 4C 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 neurons acquire their complete adult identity in the absence of Pet-1 and the number of Pet-1 resistant 5-HT neurons that exist is far fewer than previously thought (7, 13) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 16
Analysis of Slc22a3 expression in in adult
To extend this analysis to an additional key identity gene we investigated
Methods
Animals
Pet-1 -/-mice are described in Hendricks et al. 2003 . All in situ hybridizations were performed on age and sex matched adult mice 6-8 weeks of age unless otherwise stated. The National Institutes of Health guide was followed for the care and use of laboratory animals. All experiments were approved by the CWRU School of Medicine Institutional Animal Care.
Perfusion and Sectioning
Mice were anesthetized with Avertin (0.5 g tribromoethanol/39.5 ml H2O + 0.31ml tertamyl alcohol) and transcardially perfused with saline followed by cold 4% paraformaldehyde (PFA). Brains were extracted and post-fixed for 2 hrs and incubated overnight (O/N) in 30% sucrose-PBS solution at 4°C. Floating 25µm coronal brain sections of the dorsal raphe serotonin system were taken, mounted on SuperFrost Plus slides (Fisher Scientific), and dried in a vacuum chamber for at least 1hr before use.
In Situ Hybridization (ISH)
Digoxigenin (Roche Diagnostics, Indianapolis, Indiana) labeled antisense RNA probes (~600bp) were synthesized using cDNA fragments of Slc22a3, Htr1a, Gch1, Gchfr or Tph2 that were PCR amplified with reverse primers containing bacteriophage T3 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 promoter sequences at their 5' ends. A previously published in situ hybridization protocol was followed (10) .
Quantitative Real-time PCR (RT-qPCR)
RNA was isolated from E12.5 Pet-1 +/-and Pet-1 -/-animals from the rostral serotonin system using PureLinkTM RNA Mini Kit (Ambion by Life Technologies, Carlsbad, California). Purified RNA was converted to cDNA by PCR using the Transcripter FirstStrand cDNA Synthesis Kit (Roche Diagnostics, Indianapolis, Indiana) and stored at -20°C. qPCR was performed in triplicate using Fast StartTM Universal Syber Green ROX Master solution (Roche Diagnostics, Indianapolis, Indiana). Samples were normalized to β-actin.
Immunohistochemistry (IHC)
Fluorescent immunohistochemistry was performed using a polyclonal primary rabbit antibody against 5-HT (1:1000, ImmunoStar, Hudson, WI) or a primary chicken antibody against GFP (1:1000, Abcam, San Francisco, Ca) O/N at 4°C and an anti-rabbit or antichicken Alexa Fluor®488 secondary antibody (1:500, Invitrogen by Life Technologies, Carlsbad, California) for 1hr at RT in the dark. A standard IHC protocol was used (6) . Fluorescent images were taken using SPOT RT color digital camera (Diagnostic Instruments, Sterling Heights, MI) using an Olympus Optical BX51 microscope (Center Valley, PA). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 18
FACS of YFP + cells
The rostral hindbrain domain from the mesencephalic flexure to the pontine flexure of either ePet-EYFP +/+ and ePet-EYFP Pet-1-/-embryos was dissected and then treated with 0.25% trypsin-EDTA (Life Technologies) to dissociate cells as described previously (33) .
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